MedinCell secures $19Mn grant from Bill & Melinda Gates Foundation
Category: #business  By Nikita Chaurasia  Date: 2019-11-30
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

MedinCell secures $19Mn grant from Bill & Melinda Gates Foundation

MedinCell S.A., a French pharmaceutical company, has signed an agreement with the Bill & Melinda Gates Foundation for an additional $19 million that would be offered over the next four years. The arrangement focuses on funding preclinical activities along with a Phase 1 clinical study for mdc-WWM, the injectable six-month bioresorbable contraceptive. 

According to reliable sources, the grant is designed to take care of the project costs via advanced installments. Depending on the developments of the study and on options chosen, a maximum of $11.75 million can be funded over the next year which contains the first tranche of $4.75 million that needs to be paid first following the remaining $7.25 million.

Earlier in 2017, the Gates Foundation had granted a $3.5 million funding to back the formulation research phase. Meanwhile, the French pharma possesses the global marketing rights of the product, including in the U.S., where the contraceptive market has garnered over $5 billion in 2018.

In fact, LARC (Long-acting reversible contraceptives) alone held 28% of this market, valuing over $1.4 billion. The mdc-WWM product can secure an important chunk of this LARC market. Also, it has the potential to further easen the acceptance of this contraception.

Reportedly, MedinCell had prior made headlines when it collaborated with Cornerstone Animal Health to advance a variety of state-of-the-art long-acting injectable veterinary items using the its BEPO® proprietary technology.

Sources cite that Cornerstone would head the funding regulatory development and either commercialize or license the item. The agreement focuses on supporting the financial capability of BEPO® in animal health to advance MedinCell’s profitability as well as to make long-term sustainable profits. Moreover, the JV is designed to reduce the impact on the biotech’s resources and cash.

For the uninitiated, Cornerstone Animal Health is an Animal Health commercialization group based in the United States. It was created by seasoned veterans of the industry with majority of the founders being former executives of iconic firms like Merck Animal Health, Merial or Pfizer Animal Health (Zoetis).
 

Source Credit: https://www.businesswire.com/news/home/20191128005494/en/Medincell-Receives-19-Million-Grant-mdc-WWM-Program

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Moderna failed to meet FDA’s requirements for COVID-19 booster vaccines

Moderna failed to meet FDA’s requirements for COVID-19 booster vaccines

By Nikita Chaurasia

Scientists from the U.S. Food and Drug Administration (FDA) claimed that Moderna did not meet all the requirements to support the use of COVID-19 booster shots. This is because the first two shots already showed a strong efficacy rate. Documents rel...

Canada’s healthcare sector likely to brace for looming staff shortages

Canada’s healthcare sector likely to brace for looming staff shortages

By Nikita Chaurasia

According to reliable sources, Canada’s overworked healthcare sector is now bracing for upcoming staff shortages and potential layoffs, as the country accelerates its vaccination drive before the deadline. The development comes at a time when l...

Rocket Lab, Kineis sign multi-launch contract for IoT constellation

Rocket Lab, Kineis sign multi-launch contract for IoT constellation

By Nikita Chaurasia

The space industry is booming as new companies with fresh ideas for space-based applications take advantage of declining launch and satellite costs. Out of those firms, Rocket Lab USA bagged a contract to launch 25 satellites on five missions exclusi...